Professionals 233 Users Online

Chondroitin Sulfate Market

Market Study on Chondroitin Sulfate: Increasing Demand Witnessed as a Bioactive Supplement for Osteoarthritis Patients

Chondroitin Sulfate Market by form (Powder, Tablet, Capsule)

Chondroitin Sulfate Market Outlook (2023 to 2033)

The Market for Chondroitin Sulfate can be expected to expand at a value based CAGR of 3.9% and show an increase in revenue from US$ 691.40 Million to around US$ 1,013.64 Million by 2033.

Attributes Key Insights

Chondroitin Sulfate Market Size (2023E)

US$ 691.40 Million

Projected Sales of Chondroitin Sulfate (2033F)

US$ 1,013.64 Million

Value CAGR (2023 to 2033)

3.9%

Value Share of Top 4 Countries (2022E)

55%

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Chondroitin Sulfate Consumption Analysis (2018 to 2022) Vs. Market Estimations (2023 to 2033)

The global chondroitin sulfate market has witnessed significant growth in the historical period registering a CAGR of 3.95% in the historical period and was valued at US$ 691.40 Million in 2023.

Chondroitin sulfate, otherwise known as sulfated glycosaminoglycan (GAG), is composed of a huge chain of alternating sugars such as glucuronic acid and N-acetylgalactosamine. Chondroitin sulfate is a chemical compound that is present in the connective tissues in humans, which is found in the cartilages and joints of the body. Commercial chondroitin sulfate is manufactured from various animal sources such as porcine, bovine, poultry, fish, shark, crocodile, and other animals. The global market for chondroitin sulfate is estimated to reach an approximate valuation of US$ 1,013.64 Million in the forecast period.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What are the Key Trends in the Market for Chondroitin Sulfate?

Gaining Prominence as a 'Bioactive' Supplement for Osteoarthritis Patients”

Chondroitin sulfate is being widely consumed as an alternative medicine to decelerate the progression of osteoarthritis. Chondroitin sulfate also helps reduce joint pain and inflammation. Regular consumption of chondroitin sulfate leads to improved joint functions. Commercial chondroitin sulfate is a mixture of glucosamine and chondroitin sulfate. Apart from improving the joint functions, chondroitin sulfate can also be used as an eye drop for sore eyes, besides having veterinary uses.

The major cause of disability among the ageing population is osteoarthritis. When compared to men, women are more likely to be affected by osteoarthritis, and the occurrence rate also increases with age. According to the Arthritis Research United Kingdom, by 2035, around 8.3 million people in the country aged 45 years and above could have knee osteoarthritis. This rising prevalence is expected to increase the demand for chondroitin sulfate among supplement, pharmaceutical, and nutraceutical manufacturers, thereby boosting the growth of the chondroitin sulfate market.

“Increased Demand for Chondroitin Sulfate from Booming Pet Food Industry”

In the pet food industry, chondroitin sulfate is one of the established bioactive supplements that helps in supporting health benefit claims. Chondroitin sulfate is one of the key ingredients used in veterinary supplements and pet food products to avoid problems related to arthritis or hip dysplasia. Chondroitin sulfate also helps keep pets active and healthy with better joint mobility.

For instance, Zeria Group (ZPD) offers several strengths of chondroitin sulfate for the manufacturers of pet food in accordance with requirements such as different grades containing 20%, 40%, and 80% chondroitin sulfate.

“Cosmetic and Personal Care Industry Increasingly Using Chondroitin Sulfate in Natural Products”

It has been found that, chondroitin sulfate has various properties, such as its ability to moisturize, heal, and soothe the skin with its anti-inflammatory properties, and the ability to reinforce the intercellular matrix. Beauty product manufacturers are slowly adopting the usage of chondroitin sulfate in their hair care and skincare products. In 2016, Zeria Group (ZPD) offered chondroitin sulfate under its brand name ScanDroitin, for the cosmetic industry.

“Availability of Chondroitin Sulfate for Multiple Applications Boosting its Demand”

Usually, chondroitin sulfate is used in combination with various other ingredients such as N-acetyl glucosamine, manganese ascorbate, glucosamine hydrochloride, and glucosamine sulfate. With the combination of glucosamine, chondroitin sulfate is used to treat osteoarthritis, the major functional segment. There are various other end uses for chondroitin sulfate, such as cosmetics, personal care, and veterinary supplements. Increasing demand for chondroitin sulfate in multiple industries is projected to accelerate the growth of the chondroitin sulfate market over the coming years.

“Increasing Clinical Studies on Chondroitin Sulfate Determining its Superiority over Existing Products”

The presence of different pharmaceutical products for disease treatment has created a competitive market scenario for chondroitin sulfate. Several clinical studies are going on for the identification of the effectiveness of chondroitin sulfate over existing products, as well as for different indications.

In June 2017, IBSA Institute Biochimique SA conducted a clinical trial using Chondroitin Vs Celecoxib Vs Placebo Trial. The institute named the trial as CONCEPT. This trial showed that, pharmaceutical-grade chondroitin sulfate was effective as an anti-inflammatory drug when compared to Placebo Trial and Celecoxib. The trial also revealed that, chondroitin sulfate is effective for reducing joint pain and increasing the functionality of the joints among knee osteoarthritis patients.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Country-wise insights

What is the Outlook for the Global Chondroitin Sulfate Market?

North America holds a leading global chondroitin sulfate market share, followed by Europe. These two regions will continue their dominance over this space over the next decade. However, stakeholders can also look to Asia Pacific for increasing their sales and profits, as the chondroitin sulfate market in this region is projected to expand at the fastest rate through 2033.

North America represents a majority of market share in terms of value and volume, but the demand for chondroitin sulfate products is stagnant in the region. Currently, the demand for chondroitin sulfate products is increasing at significant growth in European and Asia Pacific market owing to increasing patients of osteoarthritis increasing consumption of nutraceuticals and as well as Pet food supplements for joint health. This expects to higher demand for chondroitin sulfate in near future.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Category-wise insights

What is the Segmental Breakdown of the Chondroitin Sulfate Market?

By source segment chondroitin sulfate segment includes bovine, porcine, fish, shark, & crocodile, poultry and others. On the basis of form segment chondroitin sulfate market is segmented into powder, tablet, and capsules. By end use segment, chondroitin sulfate market is segmented into cosmetics & personal care, pharmaceuticals & nutraceuticals, aqua feed, and pet food & veterinary supplements.

On the basis of sales channel, chondroitin sulfate market is segmented into direct Sales (Business to Business), indirect Sales (Business to Consumer). Further Indirect sales channel is sub-segmented into drug store & pharmacies, e-commerce channels, and other sales channel includes specialty stores and other retail outlets.

What is the Projected Growth for the Source, Form and End Use Segment of the Chondroitin Sulfate Market?

By source, the bovine segment holds the largest share in the global chondroitin sulfate market.

The powder form of chondroitin sulfate will hold over 85% of the market value share by 2033.

By end use, the pharmaceuticals and nutraceuticals segment holds the largest market share.

Competitive Dashboard

Demand for chondroitin sulfate continues to rise and the number of new entrants in this market is also increasing with growing production clusters in China. Hence, established players in the market are facing tough competition from new players. The study indicates that more than 20% market share is held by multinational players in the market. Rising demand for chondroitin sulfate and increasing number of new market players are hindering the market growth of top business ventures in the chondroitin sulfate market.

  • In February 2017, AcerChem International Inc. established its European headquarters, manufacturing, and research and development facility of chondroitin sulfate in Wales after securing funding from the Welsh Government. It established the facility at the Institute of Life Science at Swansea University.
  • In April 2015, Aoxing Biotechnology Intl Co., Limited entered into an agreement with Johnson Matthey Plc in order to establish a joint venture through affiliated companies focused on the research, development, manufacturing, and marketing of active pharmaceutical ingredients (API).
  • In April 2018, Stanford Chemicals launched chondroitin sulfate, in order to help reduce the risk of chronic eye diseases caused due to sore eyes. This high purity chondroitin sulfate is now safe to be used in food, cosmetic, and healthcare applications, and is available for customers in America and Europe.
  • In July, 2015, Bioibérica S.A. entered into collaboration with BioCeuticals, a leading Australia-based therapeutic supplement company. Under the terms of the agreement, Bioiberica will provide pharmaceutical grade chondroitin sulfate to BioCeuticals to supply in Australia.

Chondroitin Sulfate Industry Report Scope

Attribute Details

Forecast period

2023 to 2033

Historical data available for

2018 to 2022

Market analysis

USD million for value

Key regions covered

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

Key countries covered

  • United States
  • Canada
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand
  • GCC countries
  • Turkey
  • Northern Africa
  • South Africa

Key market segments covered

  • Source
  • Form
  • End Use
  • Distribution Channel
  • Region

Key companies profiled

  • TSI Group Ltd.,
  • Solabia Group
  • AcerChem International Inc.
  • Seikagaku Corporation
  • Jiaxing Hengjie Biopharmaceutical Co., Ltd
  • Aoxing Biotechnology Intl Co., Limited
  • Stanford Chemicals
  • Shanghai JBiChem International Trading Co.,Ltd.
  • Sioux Pharm, Inc.
  • Pacific Rainbow International, Inc.
  • Synutra, Inc
  • Zeria Pharmaceutical Co., Ltd.
  • Summit Nutritionals International, Inc.
  • Yantai Ruikangda Biochemical Products Co., Ltd.
  • Bioibérica S.A.
  • Dextra Laboratories Limited
  • CTPP-COPALIS
  • Derechos Reservados Syntex S.A.
  • Hebei Sanxin Industry Group Co., Ltd.
  • Sino Siam Biotechnique Co., Ltd.

Report coverage

  • Market forecast
  • Company share analysis
  • Competition intelligence
  • DROT analysis
  • Market dynamics and challenges
  • Strategic growth initiatives

Customization & pricing

Available upon request

Chondroitin Sulfate Industry Research by Category

By Source:

  • Bovine
  • Porcine
  • Poultry
  • Fish, Shark & Crocodiles
  • Others

By Form:

  • Powder
  • Tablet
  • Capsules

By End Use:

  • Cosmetics & Personal Care
  • Pharmaceutical and Nutraceutical
  • Aqua feed
  • Pet food and veterinary supplements

By Distribution Channel:

  • Business to Business
  • Business to Consumer
    • Drug Store & Pharmacies
    • e-Commerce Channels
    • Other sales channel

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa

- Companies Covered in This Report -

  • TSI Group Ltd
  • Solabia Group
  • AcerChem International Inc.
  • Seikagaku Corporation
  • Jiaxing Hengjie Biopharmaceutical Co., Ltd
  • Aoxing Biotechnology Intl Co., Limited
  • Stanford Chemicals
  • Shanghai JBiChem International Trading Co.,Ltd.
  • Sioux Pharm, Inc.
  • Pacific Rainbow International, Inc.
  • Synutra, Inc
  • Zeria Pharmaceutical Co., Ltd.
  • Summit Nutritionals International, Inc.
  • Yantai Ruikangda Biochemical Products Co., Ltd.
  • Bioibérica S.A.
  • Dextra Laboratories Limited
  • CTPP-COPALIS
  • Derechos Reservados Syntex S.A.
  • Hebei Sanxin Industry Group Co., Ltd.
  • Sino Siam Biotechnique Co., Ltd.

- Frequently Asked Questions -

The global market for chondroitin sulfate has a value of US$ 691.40 Mn in 2023.

The global market for chondroitin sulfate has a value CAGR of 3.95% from 2018-2022.

The global market for chondroitin sulfate has a value of US$ 1,013.64 Mn in 2033.

The global market for chondroitin sulfate has a value CAGR of 3.9% from 2023-2033.

The top players hold more than 20-30% of the market share. They include TSI Group Ltd.  Synutra, Inc., Bioiberica, Sanxin Group, Sino Siam Biotechnique Co., Ltd.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate